Basit öğe kaydını göster

dc.contributor.authorOzmen, Deniz
dc.contributor.authorAyer, Mesut
dc.contributor.authorELİBOL, TAYFUN
dc.contributor.authorAyer, Fatma Aylin
dc.contributor.authorAkay, Cagan M.
dc.date.accessioned2021-03-03T09:39:56Z
dc.date.available2021-03-03T09:39:56Z
dc.date.issued2018
dc.identifier.citationAyer M., Akay C. M. , Ayer F. A. , Ozmen D., ELİBOL T., "Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors", HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, cilt.56, sa.3, ss.181-186, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_1e34ddd4-b832-46a3-81d0-7cd16cb53e05
dc.identifier.urihttp://hdl.handle.net/20.500.12627/25461
dc.identifier.urihttps://doi.org/10.4274/haseki.85057
dc.description.abstractAim: Chronic lymphocytic leukemia (CLL) is a heterogenous disease with variable clinical course. Rai staging system is used for at least 40 years to predict prognosis and need for treatment but more prognostic factors are needed. Infections have been known to have a significant impact on patients with CLL. It is postulated that hypogammaglobulinemia accounts for the high infection rate. The severity of hypogammaglobulinemia is correlated with disease stage and duration.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectTemel Tıp Bilimleri
dc.titleEvaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors
dc.typeMakale
dc.relation.journalHASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume56
dc.identifier.issue3
dc.identifier.startpage181
dc.identifier.endpage186
dc.contributor.firstauthorID256142


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster